Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Horizon Therapeutics (NQ: HZNP ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 5, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Horizon Therapeutics < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > New TEPEZZA® (teprotumumab-trbw) Data to be Presented at the American Academy of Ophthalmology (AAO) 2021 Annual Meeting October 12, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc to Release Third-Quarter 2021 Financial Results and Host Webcast on Nov. 3, 2021 October 11, 2021 From Horizon Therapeutics plc Via Business Wire Innoviva Stock In Buy Range; Joins Ranks Of Top-Performing Stocks With Strength Ratings Over 90 October 08, 2021 Innoviva stock is within a buy range after climbing above a 16.82 entry in a flat base. The proper buying range is up to 5% above the entry. Via Investor's Business Daily Horizon Therapeutics plc Named One of the 2021 Top 100 Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption October 06, 2021 From Horizon Therapeutics plc Via Business Wire Analyzing Horizon Therapeutics's Unusual Options Activity August 11, 2021 On Wednesday, shares of Horizon Therapeutics (NASDAQ:HZNP... Via Benzinga Understanding Horizon Therapeutics's Unusual Options Activity August 10, 2021 On Tuesday, shares of Horizon Therapeutics (NASDAQ:HZNP) ... Via Benzinga Alkermes Stock Composite Rating Rises To Near-Perfect 96 As It Posts Erratic But Huge Sales Gains October 05, 2021 The IBD SmartSelect Composite Rating for Alkermes rose from 94 to 96 Tuesday. Via Investor's Business Daily New Analysis Published in Multiple Sclerosis Journal Assesses Long-Term Use of UPLIZNA® (inebilizumab-cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) October 04, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2021 October 04, 2021 From Horizon Therapeutics plc Via Business Wire The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO August 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga Analyzing Horizon Therapeutics's Unusual Options Activity August 04, 2021 Horizon Therapeutics (NASDAQ:HZNP) shares experienced unus... Via Benzinga The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga Datadog, Netflix Lead Five Stocks Standing Tall In Market Correction October 02, 2021 In a market correction, look for stocks with strong relative lines such as Netflix and Datadog. Via Investor's Business Daily SEC Charges Former Goldman Sachs Officer For Insider Trading On 2 M&A Deals October 01, 2021 The Securities and Exchange Commission has charged a former Goldman Sachs (NYSE: GS) compliance analyst with using confidential information to generate over $... Via Benzinga Topics Regulatory Compliance Exposures Legal Regulatory Horizon Therapeutics plc Announces New Development Programs at Virtual R&D Day September 29, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces Agenda for Virtual R&D Day for Investors and Analysts on Sept. 29, 2021 September 23, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Announces Data Showing UPLIZNA® (inebilizumab-cdon) Also Produces Rapid and Sustained B-Cell Depletion in African Americans with Neuromyelitis Optica Spectrum Disorder (NMOSD) September 23, 2021 From Horizon Therapeutics plc Via Business Wire 9 Health Care Stocks Showing Unusual Options Activity In Today's Session September 21, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Horizon Therapeutics plc Announces New Genetic Counselor Curated Algorithms and Next-Generation Sequencing Data as Winning Solutions of First-Ever Horizon Prize, Powered by MIT Solve, to Accelerate Rare Disease Diagnosis September 21, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Named One of the 2021 Best Workplaces for Women™ by Fortune and Great Place to Work® September 16, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Initiates Randomized Controlled Clinical Trial Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Chronic (Inactive) Thyroid Eye Disease (TED) September 07, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc Named One of PEOPLE’s 100 Companies That Care® September 01, 2021 From Horizon Therapeutics plc Via Business Wire Horizon Therapeutics plc to Participate in Upcoming Conferences August 23, 2021 From Horizon Therapeutics plc Via Business Wire 9 Health Care Stocks With Unusual Options Alerts In Today's Session August 23, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Horizon Therapeutics PLC (HZNP) Q2 2021 Earnings Call Transcript August 04, 2021 HZNP earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Horizon Therapeutics Stock Shoots Higher As Relaunch Of Thyroid Eye Disease Med Boosts Q2 Sales; Raises FY21 Outlook August 04, 2021 Horizon Therapeutics plc (NASDAQ: HZNP) stock is gaining amid second-quarter solid earnings after reporting adjusted EPS of $1.62, almost tripled from $0.40 posted a... Via Benzinga Horizon Stock Extends Its Record Breakout As Key Drug Recovers From Covid Struggle August 04, 2021 Horizon Therapeutics topped Wall Street's second-quarter forecasts on Wednesday, helping HZNP stock extend a pre-earnings breakout. Via Investor's Business Daily Horizon Therapeutics: Q2 Earnings Insights August 04, 2021 Shares of Horizon Therapeutics (NASDAQ:HZNP) moved higher by 9.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up... Via Benzinga Horizon Therapeutics plc Reports Record Second-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance August 04, 2021 From Horizon Therapeutics plc Via Business Wire The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings August 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga < Previous 1 2 ... 10 11 12 13 14 15 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.